✦ LIBER ✦

Antifibrotic targets and therapy in HCV

✍ Scribed by Efsevia Albanis; Scott L. Friedman

Book ID: 107540433
Publisher: Current Science Inc.
Year: 2006
Tongue: English
Weight: 323 KB
Volume: 5
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-006-0011-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Efsevia Albanis; Scott L. Friedman 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 535 KB

Rationale and targets for antifibrotic t

Rationale and targets for antifibrotic therapies

✍ Schuppan, D.; Popov, Y. 📂 Article 📅 2009 🏛 Masson Editeur 🌐 French ⚖ 876 KB

First-in-class antifibrotic therapy targ

First-in-class antifibrotic therapy targeting type 1 lysophosphatidic acid receptor

✍ Im, Dong-Soon 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 613 KB

Antifibrotic therapy in scleroderma: Ext

Antifibrotic therapy in scleroderma: Extracellular or intracellular targeting of activated fibroblasts?

✍ John Varga 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 596 KB

Targeting liver fibrosis: Strategies for

Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies

✍ Yury Popov; Detlef Schuppan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 1 views

We have made striking progress in our understanding of the biochemistry and cell biology that underlies liver fibrosis and cirrhosis, including the development of strategies and agents to prevent and reverse fibrosis. However, translation of this knowledge into clinical practice has been hampered by

Antifibrotic therapy in pancreatic disea

Antifibrotic therapy in pancreatic diseases

✍ Erkan, M. 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 108 KB